GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Price-to-Funds-From-Operations

Vaxcyte (FRA:5VA) Price-to-Funds-From-Operations : (As of Apr. 12, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcyte Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Vaxcyte Business Description

Industry
Traded in Other Exchanges
Address
825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.